Gilead Sciences Suffers ‘Sloppy’ Quarter on ‘Unimportant’ Sovaldi Sales

Shares of Gilead Sciences (GILD) are falling today after the biotech giant released earnings that the missed the Street consensus. Associated Press Gilead reported a profit of $1.84 a share, missing forecasts for $1.93, on sales of $6.04 billion. Gilead’s earnings were hit by the so-called Branded Prescription Drug Fee, an excise tax included in [...]